Bulletin
Investor Alert

Revolution Medicines Inc.

NAS: RVMD

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Revolution Medicines Inc.

After Hours

 --Quotes are delayed by 20 min

Aug 18, 2022, 4:05 p.m.

RVMD
/zigman2/quotes/216320743/composite

$

23.00

Change

-0.05 -0.22%

Volume

Volume 10,275

Quotes are delayed by 20 min

/zigman2/quotes/216320743/composite

Today's close

$ 24.20

$ 23.05

Change

-1.15 -4.75%

Day low

Day high

$22.04

$23.87

Open

52 week low

52 week high

$14.08

$34.16

Open
Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Revolution Medicines Inc.

View Ratios
Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue -20.17M50.04M42.98M29.39M
Cost of Goods Sold (COGS) incl. D&A 1.19M---7.33M
COGS excluding D&A -----
Depreciation & Amortization Expense 1.19M1.76M3.34M6.55M7.33M
Depreciation 1.19M1.57M2.27M5.48M6.26M
Amortization of Intangibles -198,0001.07M1.07M1.07M
Gross Income (1.19M)---22.06M
20172018201920202021 5-year trend
SG&A Expense 29.94M58.33M100.22M147.14M210.07M
Research & Development 26.59M51.08M91.16M128.57M182.8M
Other SG&A 3.36M7.25M9.06M18.56M-
Other Operating Expense -----
Unusual Expense -2.52M---
EBIT after Unusual Expense -(42.45M)---
Non Operating Income/Expense --(597,000)--
Non-Operating Interest Income 105,000777,0002.19M2.24M929,000
Equity in Affiliates (Pretax) -----
Interest Expense 103,000116,000106,00071,00012,000
Gross Interest Expense 103,000116,000106,00071,00012,000
Interest Capitalized -----
Pretax Income (31.13M)(41.79M)(52.04M)(108.53M)(187.09M)
Income Tax --(4.37M)(371,000)-
Income Tax - Current Domestic --(4.37M)(371,000)-
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (31.13M)(41.79M)(47.66M)(108.16M)(187.09M)
Minority Interest Expense -----
Net Income (31.13M)(41.79M)(47.66M)(108.16M)(187.09M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (31.13M)(41.79M)(47.66M)(108.16M)(187.09M)
Preferred Dividends 3.76M7.03M14.24M2.22M-
Net Income Available to Common (34.89M)(48.82M)(61.9M)(110.38M)(187.09M)
EPS (Basic) (0.59)(0.83)(1.05)(1.66)(2.57)
Basic Shares Outstanding 59M59M59M66.6M72.81M
EPS (Diluted) (0.59)(0.83)(1.05)(1.66)(2.57)
Diluted Shares Outstanding 59M59M59M66.6M72.81M
EBITDA (29.94M)(38.17M)(50.18M)(104.15M)(180.68M)
Copyright 2022 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Link to MarketWatch's Slice.